The contraction phase of virus-specific CD8+ T cells is unaffected by a pan-caspase Inhibitor

Journal of Immunology

Volumn 173, Issue 11, 2004, Pages 6611-6618

  Nussbaum, Alexander K ^a   Whitton, J Lindsay ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3; FAS ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CYCLE; CONTROLLED STUDY; DRUG TOLERANCE; ENZYME ACTIVATION; IMMUNE RESPONSE; LIVER CELL; LIVER HEMORRHAGE; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TISSUE CULTURE; VIRUS MENINGITIS;

EID: 9144253961     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.11.6611     Document Type: Article

References (74)

1. Welsh, R. M., and J. M. McNally. 1999. Immune deficiency, immune silencing, and clonal exhaustion of T cell responses during viral infections. Curr. Opin. Microbiol. 2:382.
2. + T cell responses. Curr. Opin. Immunol. 12:448.
3. Kaech, S. M., E. J. Wherry, and R. Ahmed. 2002. Effector and memory T-cell differentiation: Implications for vaccine development. Nat. Rev. Immunol. 2:251.
4. + T cell response to infection. Curr. Opin. Immunol. 14:360.
5. Murali-Krishna, K., J. D. Altman, M. Suresh, D. J. Sourdive, A. J. Zajac, J. D. Miller, J. Slansky, and R. Ahmed. 1998. Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection. Immunity 8:177.
6. + stability? Nat. Med. 7:892.
7. Sprent, J., and D. F. Tough. 2001. T cell death and memory. Science 293:245.
8. Lin, M. Y., and R. M. Welsh. 1998. Stability and diversity of T cell receptor repertoire usage during lymphocytic choriomeningitis virus infection of mice. J. Exp. Med. 188:1993.
9. + T cell response. Immunity 18:549.
10. Rodriguez, F., L. L. An, S. Harkins, J. Zhang, M. Yokoyama, G. Widera, J. T. Fuller, C. Kincaid, I. L. Campbell, and J. L. Whitton. 1998. DNA immunization with minigenes: Low frequency of memory CTL and inefficient antiviral protection are rectified by ubiquitination. J. Virol. 72:5174.
11. + T cell numbers. J. Immunol. 171:4254.
12. + T-cell memory determined by clonal burst size. Nature 369:652.
13. Welsh, R. M., L. K. Selin, and E. S. Razvi. 1995. Role of apoptosis in the regulation of virus-induced T cell responses, immune suppression, and memory. J. Cell. Biochem. 59:135.
14. Lenardo, M., K. M. Chan, F. Hornung, H. McFarland, R. Siegel, J. Wang, and L. Zheng. 1999. Mature T lymphocyte apoptosis - Immune regulation in a dynamic and unpredictable antigenic environment. Annu. Rev. Immunol. 17:221.
15. Janssen, O., R. Sanzenbacher, and D. Kabelitz. 2000. Regulation of activation-induced cell death of mature T-lymphocyte populations. Cell Tissue Res. 301:85.
16. Newton, K., C. Kurts, A. W. Harris, and A. Strasser. 2001. Effects of a dominant interfering mutant of FADD on signal transduction in activated T cells. Curr. Biol. 11:273.
17. Hildeman, D. A., Y. Zhu, T. Mitchell, J. Kappler, and P. Marrack. 2002. Molecular mechanisms of activated T cell death in vivo. Curr. Opin. Immunol. 14:354.
18. Marrack, P., and J. Kappler. 2004. Control of T cell viability. Annu. Rev. Immunol. 22:765.
19. Alderson, M. R., T. W. Tough, T. Davis-Smith, S. Braddy, B. Falk, K. A. Schooley, R. G. Goodwill, C. A. Smith, F. Ramsdell, and D. H. Lynch. 1995. Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 181:71.
20. Brunner, T., R. J. Mogil, D. LaFace, N. J. Yoo, A. Mahboubi, F. Echeverri, S. J. Martin, W. R. Force, D. H. Lynch, and C. F. Ware. 1995. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373:441.
21. Ju, S. T., D. J. Panka, H. Cui, R. Ettinger, M. el Khatib, D. H. Sherr, B. Z. Stanger, and A. Marshak-Rothstein. 1995. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373:444.
22. Zaks, T. Z., D. B. Chappell, S. A. Rosenberg, and N. P. Restifo. 1999. Fas-mediated suicide of tumor-reactive T cells following activation by specific tumor: Selective rescue by caspase inhibition. J. Immunol. 162:3273.
23. Nguyen, L. T., K. McKall-Faienza, A. Zakarian, D. E. Speiser, T. W. Mak, and P. S. Ohashi. 2000. TNF receptor 1 (TNFR1) and CD95 are not required for T cell deletion after virus infection but contribute to peptide-induced deletion under limited conditions. Eur. J. Immunol. 30:683.
24. Sobek, V., S. Balkow, H. Korner, and M. M. Simon. 2002. Antigen-induced cell death of T effector cells in vitro proceeds via the Fas pathway, requires endogenous interferon-γ and is independent of perform and granzymes. Eur. J. Immunol. 32:2490.
25. Nagata, S., and T. Suda. 1995. Fas and Fas ligand: lpr and gld mutations. Immunol. Today 16:39.
26. Razvi, E. S., Z. Jiang, B. A. Woda, and R. M. Welsh. 1995. Lymphocyte apoptosis during the silencing of immune response to acute viral infections in normal, lpr, and Bcl-2-transgenic mice. Am. J. Pathol. 147:79.
27. Lohman, B. L., E. S. Razvi, and R. M. Welsh. 1996. T-lymphocyte downregulation after acute viral infection is not dependent on CD95 (Fas) receptor-ligand interactions. J. Virol. 70:8199.
28. Lohman, B. L., and R. M. Welsh. 1998. Apoptotic regulation of T cells and absence of immune deficiency in virus-infected γ interferon receptor knockout mice. J. Virol. 72:7815.
29. Reich, A., H. Korner, J. D. Sedgwick, and H. Pircher. 2000. Immune down-regulation and peripheral deletion of CD8 T cells does not require TNF receptor-ligand interactions nor CD95 (Fas, APO-1). Eur. J. Immunol. 30:678.
30. Hieronymus, T., N. Blank, M. Gruenke, S. Winkler, J. P. Haas, J. R. Kalden, and H. M. Lorenz. 2000. CD 95-independent mechanisms of IL-2 deprivation-induced apoptosis in activated human lymphocytes. Cell Death. Differ. 7:538.
31. Hildeman. D. A., Y. Zhu, T. C. Mitchell, P. Bouillet, A. Strasser, J. Kappler, and P. Marrack. 2002. Activated T cell death in vivo mediated by proapoptotic bcl-2 family member bim. Immunity 16:759.
32. Cohen, G. M. 1997. Caspases: The executioners of apoptosis. Biochem. J. 326:1.
33. Thornberry, N. A., and Y. Lazebnik. 1998. Caspases: Enemies within. Science 281:1312.
34. Rodriguez, I., K. Matsuura, C. Ody, S. Nagata, and P. Vassalli. 1996. Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death. J. Exp. Med. 184:2067.
35. Kunstle, G., M. Leist, S. Uhlig, L. Revesz, R. Feifel, A. Mackenzie, and A. Wendel. 1997. ICE-protease inhibitors block murine liver injury and apoptosis caused by CD95 or by TNF-α. Immunol. Lett. 55:5.
36. Braun, J. S., R. Novak, K. H. Herzog, S. M. Bodner, J. L. Cleveland, and E. I. Tuomanen. 1999. Neuroprotection by a caspase inhibitor in acute bacterial meningitis. Nat. Med. 5:298.
37. Li, M., V. O. Ona, C. Guegan, M. Chen, V. Jackson-Lewis, L. J. Andrews, A. J. Olszewski, P. E. Stieg, J. P. Lee, S. Przedborski, and R. M. Friedlander. 2000. Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science 288:335.
38. Hotchkiss, R. S., K. W. Tinsley, P. E. Swanson, K. C. Chang, J. P. Cobb, T. G. Buchman, S. J. Korsmeyer, and I. E. Karl. 1999. Prevention of lymphocyte cell death in sepsis improves survival in mice. Proc. Natl. Acad. Sci. USA 96:14541.
39. Hotchkiss, R. S., K. C. Chang, P. E. Swanson, K. W. Tinsley, J. J. Hui, P. Klender, S. Xanthoudakis, S. Roy, C. Black, E. Grimm, R. Aspiotis, Y. Han, D. W. Nicholson, and I. E. Karl. 2000. Caspase inhibitors improve survival in sepsis: A critical role of the lymphocyte. Nat. Immunol. 1:496.
40. Ferraro-Peyret, C., L. Quemeneur, M. Flacher, J. P. Revillard, and L. Genestier. 2002. Caspase-independent phosphatidylserine exposure during apoptosis of primary T lymphocytes. J. Immunol. 169:4805.
41. + T cells. Nature 401:76.
42. + T cells during viral infection. J. Immunol. 170:4745.
43. + T cells without selection of higher affinity TCR. Nat. Immunol. 2:711.
44. Sallusto, F., D. Lenig, R. Forster, M. Lipp, and A. Lanzavecchia. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401:708.
45. - memory T cells do not differ in immediate effector cell function. J. Immunol. 169:638.
46. + memory cells in humans defined by HLA and CC chemokine ligand 19 tetramers. J. Immunol. 170:2461.
47. Wherry, E. J., V. Teichgraber, T. C. Becker, D. Masopust, S. M. Kaech, R. Antia, U. H. von Andrian, and R. Ahmed. 2003. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat. Immunol. 4:225.
48. Ogasawara, J., R. Watanabe-Fukunaga, M. Adachi, A. Matsuzawa, T. Kasugai, Y. Kitamura, N. Itoh, T. Suda, and S. Nagata. 1993. Lethal effect of the anti-Fas antibody in mice. Nature 364:806.
49. Budd, R. C. 2001. Activation-induced cell death. Curr. Opin. Immunol. 13:356.
50. Hotchkiss, R. S., P. E. Swanson, B. D. Freeman, K. W. Tinsley, J. P. Cobb, G. M. Matuschak, T. G. Buchman, and I. E. Karl. 1999. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit. Care Med. 27:1230.
51. + T lymphocytes in humans. J. Immunol. 166:6952.
52. Woo, M., A. Hakem, A. J. Elia, R. Hakem, G. S. Duncan, B. J. Patterson, and T. W. Mak. 1999. In vivo evidence that caspase-3 is required for Fas-mediated apoptosis of hepatocytes. J. Immunol. 163:4909.
53. Zender, L., S. Hutker, C. Liedtke, H. L. Tillmann, S. Zender, B. Mundt, M. Waltemathe, T. Gosling, P. Flemming, N. P. Malek, C. Traulwein, M. P. Manns, F. Kuhnel, and S. Kubicka. 2003. Caspase 8 small interfering RNA prevents acute liver failure in mice. Proc. Natl. Acad. Sci. USA 100:7797.
54. Lacronique, V., A. Mignon, M. Fahre, B. Viollet, N. Rouquet, T. Molina, A. Porteu, A. Henrion, D. Bouscary, P. Varlet, V. Joulin, and A. Kahn. 1996. Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice. Nat. Med. 2:80.
55. Rodriguez, I., K. Matsuura, K. Khatib, J. C. Reed, S. Nagata, and P. Vassalli. 1996. A bcl-2 transgene expressed in hepatocytes protects mice from fulminant liver destruction but not from rapid death induced by anti-Fas antibody injection. J. Exp. Med. 183:1031.
56. + T cells by the normal liver. J. Immunol. 163:3202.
57. Park, S., D. Murray, B. John, and I. N. Crispe. 2002. Biology and significance of T-cell apoptosis in the liver. Immunol. Cell Biol. 80:74.
58. Hildeman, D. A., T. Mitchell, T. K. Teague, P. Henson, B. J. Day, J. Kappler, and P. C. Marrack. 1999. Reactive oxygen species regulate activation-induced T cell apoptosis. Immunity 10:735.
59. Doerfler, P., K. A. Forbush, and R. M. Perlmutter. 2000. Caspase enzyme activity is not essential for apoptosis during thymocyte development. J. Immunol. 164:4071.
60. Holler, N., R. Zaru, O. Micheau, M. Thome, A. Attinger, S. Valitutti, J. L. Bodmer, P. Schneider, B. Seed, and J. Tschopp. 2000. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat. Immunol. 1:489.
61. Pettersen, R. D., G. Bernard, M. K. Olafsen, M. Pourtein, and S. O. Lie. 2001. CD99 signals caspase-independent T cell death. J. Immunol. 166:4931.
62. Uzzo, R. G., N. Dulin, T. Bloom, R. Bukowski, J. H. Finke, and V. Kolenko. 2001. Inhibition of NFκB induces caspase-independent cell death in human T lymphocytes. Biochem. Biophys. Res. Commun. 287:895.
63. Jung, K. C., W. S. Park, H. J. Kim, E. Y. Choi, M. C. Kook, H. W. Lee, and Y. Bae. 2004. TCR-independent and caspase-independent apoptosis of murine thymocytes by CD24 cross-linking. J. Immunol. 172:795.
64. Bidere, N., and A. Senik. 2001. Caspase-independent apoptotic pathways in T lymphocytes: a minireview. Apoptosis 6:371.
65. Jaattela, M., and J. Tschopp. 2003. Caspase-independent cell death in T lymphocytes. Nat. Immunol. 4:416.
66. Davidson, W. F., C. Haudenschild, J. Kwon, and M. S. Williams. 2002. T cell receptor ligation triggers novel nonapoptotic cell death pathways that are Fas-independent or Fas-dependent. J. Immunol. 169:6218.
67. Rathmell, J. C., T. Lindsten, W. X. Zong, R. M. Cinalli, and C. B. Thompson. 2002. Deficiency in Bak and Bax perturbs thymic selection and lymphoid homeostasis. Nat. Immunol. 3:932.
68. Sandalova, E., C. H. Wei, M. G. Masucci, and V. Levitsky. 2004. Regulation of expression of Bcl-2 protein family member Birn by T cell receptor triggering. Proc. Nalt. Acad. Sci. USA 101:3011.
69. Bouillet, P., D. Metcalf, D. C. Huang, D. M. Tarlinton, T. W. Kay, F. Kontgen, J. M. Adams, and A. Strasser. 1999. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286:1735.
70. Pellegrini, M., G. Belz, P. Bouillet, and A. Strasser. 2003. Shutdown of an acute T cell immune response to viral infection is mediated by the proapoptotic Bcl-2 homology 3-only protein Bim. Proc. Natl. Acad. Sci. USA 100:14175.
71. Newton, K., and A. Strasser. 2003. Caspases signal not only apoptosis but also antigen-induced activation in cells of the immune system. Genes Dev. 17:819.
72. Mack, A., and G. Hacker. 2002. Inhibition of caspase or FADD function blocks proliferation but not MAP kinase-activation and interleukin-2-production during primary stimulation of T cells. Eur. J. Immunol. 32:1986.
73. Iwata, A., K. Nishio, R. K. Winn, E. Y. Chi, W. R. Henderson, Jr., and J. M. Harlan. 2003. A broad-spectrum caspase inhibitor attenuates allergic airway inflammation in murine asthma model. J. Immunol. 170:3386.
74. Cassens, U., G. Lewinski, A. K. Samraj, H. von Bernuth, H. Baust, K. Khazaie, and M. Los. 2003. Viral modulation of cell death by inhibition of caspases. Arch. Immunol. Ther. Exp. 51:19.